Japan Tightens Insurance Distribution Governance

Japan’s latest insurance reforms are not only about stricter oversight. They are about what happens when a distributor becomes commercially important enough that the relationship around the insurance product starts to influence the product itself.

For international companies, that distinction matters.

Japan’s distribution market often works through agencies that are not simply insurance sellers. They may also be car dealers, repair businesses, property companies, retailers or other operating businesses. The relationship between insurer and distributor can therefore include much more than insurance commissions.

The reforms taking effect from 2026 through 2028 put clearer boundaries around that wider relationship — and around the influence it can have on customer recommendations.

Why Japan changed the rules

The reform did not emerge from a single scandal. But the insurance-claim misconduct involving Bigmotor made one structural weakness difficult to ignore.

The immediate case involved improper repair work and inflated insurance claims. The wider regulatory review exposed a deeper issue: a large agency can generate enough business to become commercially important to an insurer, making effective challenge harder in practice. The FSA’s review put that structurally — the guidance, management and check-and-balance function over large multi-agency intermediaries bringing in substantial premium income was not working sufficiently, and the agency’s own scale was the source of its influence over the insurer⁷.

It also examined vehicle-repair referrals. Insurers may refer policyholders to repair businesses after an accident, a practice the review treats as having advantages for the customer, the insurer and the repair shop alike. But it identified cases where those referrals sat inside a reciprocal commercial relationship with insurance business — referrals made in the expectation of winning insurance contracts through the agency that also ran the repair shop, and referrals that continued even though improper repair-cost claims were being made there⁷.

The important question is therefore not simply “What did Bigmotor do?” It is “What did the case reveal about the way insurers and powerful distributors can become commercially dependent on each other?” That is the structural problem behind the newer framework.

The subsequent reform programme reaches beyond claims handling into large-agency governance, benefit provision, secondments, side businesses, comparative recommendation selling and conflicts of interest⁷. Seen together, those measures are easier to understand as an attempt to govern the commercial relationship around insurance distribution, not only the insurance transaction itself.

What changed in 2026

From 1 June 2026, the first tranche strengthened governance around large intermediaries and the commercial relationships surrounding them¹.

Large intermediaries carry stronger obligations of their own

Japanese insurance distribution has historically relied substantially on insurers to supervise the agencies selling their products. The new framework places systems-development obligations directly on a defined category of large multi-agency intermediaries. Qualification turns on statutory criteria including commission scale; the full test is more detailed than this article needs to reproduce³.

For an international company, the important shift is in responsibility: a sufficiently large distributor is no longer treated only as something the insurer supervises; it carries governance obligations of its own.

Insurers must govern these relationships more explicitly

Insurers were not previously operating without agency controls. What changes is the formality expected around relationships with qualifying large intermediaries. An insurer entrusting business to one of these firms must establish an entrustment policy and assign responsible management². That matters because formal oversight can become harder to exercise when an agency is commercially important enough to the insurer.

Commercial support faces closer scrutiny

The reforms also sharpen scrutiny of benefit provision — 便宜供与 — from insurers to agencies. This is not a blanket prohibition on commercial support².

Two types of arrangement are treated more directly as excessive: where benefit provision is linked to adjustments in policy volumes or underwriting share, and where an agency sets sales targets or purchase quotas for the insurer. Other arrangements are assessed case by case, considering factors including purpose, price, quantity, frequency, duration, who bears the cost and the potential harm created⁵. That distinction matters because an insurer–agency relationship may include secondments, purchases, referrals, services, cost-bearing and other forms of support in addition to commission.

The part an international reader may miss

This section is Eveil’s interpretation of the practical implications, not a position stated by the regulator.

For an overseas executive, insurance distribution can look like a relatively clean chain:

insurer → distributor → customer

Japan can be more complicated. A distributor may also be an automotive business, repair network, property company, retailer or another enterprise with its own economic relationship with the insurer. That creates a second layer of economics around the insurance transaction.

A partner may matter not only because it sells insurance, but because the wider relationship includes referrals, purchases, staffing support, services, customer access or other commercial value.

That is where three questions can begin to blur:

• Who supervises whom?
• What determines which product is recommended?
• Whose interests are driving the relationship?

The point is not that broader commercial relationships are inherently problematic. It is that, once they become valuable enough, they can alter the balance of influence between insurer and distributor.

For an international entrant, that changes what partner due diligence needs to examine.

Why 2028 matters

The second major step takes effect on 1 March 2028 and reaches more directly into how multi-agency intermediaries compare and recommend products to customers⁴.

Where an intermediary selects among comparable products, it will be expected to establish what matters to the customer and explain the basis for the recommendation. Where one product is specifically recommended, the reasoning is expected to be sufficiently concrete and reasonable, reflect the customer’s best interests, and not simply reflect the convenience or commercial interests of the intermediary.

The FSA expressly addresses the risk of an apparently objective recommendation being driven in substance by factors such as higher commission levels or benefits received by the agency⁶.

A useful way to interpret the sequence is:

2026 governs more of the commercial relationship around the recommendation. 2028 tightens the recommendation itself.

That is Eveil’s interpretation rather than the FSA’s formal description, but the connection is explicit.

From 2028, the intermediary’s own checks must consider whether benefit provision or secondments are impairing appropriate product choice⁶. The 2026 framework already requires qualifying intermediaries to describe how they verify the effect of dealings with insurers on comparative recommendation selling².

The commercial relationship and the customer recommendation are therefore not separate regulatory stories. They are two ends of the same one.

What this means for international companies

For a foreign insurer, InsurTech or service provider entering Japan through partners, the lesson is broader than regulatory compliance.

A strong Japanese partner may bring distribution reach, customer access and credibility. But reach alone is not enough.

What to validate next The more useful questions are:

• What other commercial relationships exist between this partner and insurers?
• What incentives sit around the insurance transaction?
• How independently can the partner compare and recommend products?
• Who is accountable for identifying and managing conflicts?
• If the partner becomes strategically important, does the governance remain strong enough to challenge it?

For companies offering technology, wellbeing, assistance, rewards or other services around insurance, the same principle applies.

The issue is not whether additional customer value can be created. It is whether that value belongs to the insurance proposition, or whether the commercial arrangements surrounding it begin to influence which insurer or product gets recommended.

That becomes particularly important where the commercial logic of a partnership is that the partner will “push” one provider’s proposition. The question is no longer only whether that arrangement works commercially. It is whether the recommendation can still stand independently on the merits of the product and the customer’s needs.

Eveil view

Japan’s reform is ultimately about commercial dependence.

The lesson from the earlier misconduct cases was not simply that some controls failed. It was that the balance between insurer and distributor can shift when an agency becomes commercially important enough. At that point, the relationship itself becomes a governance risk.

That does not mean close commercial relationships are inherently problematic, or that support between insurer and distributor should disappear. It means the economics around the relationship need to remain separable from the logic by which a product is recommended to the customer.

For international companies, that is the point worth remembering when evaluating a Japan distribution partner. The strongest partner is not necessarily the one with the largest reach. It is the one whose economics, governance and recommendation process can still be explained — and challenged — when the commercial relationship becomes valuable.

The management question is therefore not only “Can this partner sell for us?” It is “If this partnership becomes commercially important to both sides, what keeps that commercial dependence from determining what the customer is recommended?”

That is why these reforms are useful beyond compliance. They reveal how Japan’s insurance market actually works: not only through products and commissions, but through a wider network of commercial relationships that can shape who has influence, who can challenge whom, and ultimately what reaches the customer.

Need to understand what changes in Japan’s distribution framework mean for your market strategy or partner model? Eveil Intelligence is structured work on one organisation’s question.